SUBSCRIBE
SUBSCRIBE
News   FDA

GlaxoSmithKline Gets FDA Okay for Prostate Combination Drug

June 15, 2010 | 
1 min read
Reuters -- GlaxoSmithKline (GSK.L) has won U.S. approval for a fixed-dose combination prostate drug called called Jalyn, combining dutasteride and tamsulosin.
FDA Approvals
GlaxoSmithKline Food and Drug Administration (FDA)
MORE ON THIS TOPIC
FDA
FDA’s AI Rollout Raises Questions Around Readiness, Legality
June 30, 2025
 · 
6 min read
 · 
Natalia Mesa
Facade of the FDA's office in Maryland
Approvals
Moderna, Merck, UroGen, Score RSV and Cancer Nods in June
June 30, 2025
 · 
9 min read
 · 
Tristan Manalac
Vaccines
ACIP Skips Votes on COVID and Moderna’s mRESVIA but Scrutinzes mRNA Vaccine Safety
June 27, 2025
 · 
2 min read
 · 
Jef Akst
Wooden blocks with arrow and error icon. Delays and disruptions, stop the process, critical error concept
Neurodegenerative disease
Edgewise Takes a Hit as FDA Blocks Accelerated Path for Becker Muscular Dystrophy Drug
June 27, 2025
 · 
2 min read
 · 
Tristan Manalac